Store-operated calcium (Ca 2+) entry (SOCE) occurs through a widely distributed family of ion channels activated by the loss of Ca 2+ from the endoplasmic reticulum (ER). The best understood of these is the Ca 2+ release-activated Ca 2+ (CRAC) channel, which is notable for its unique activation mechanism as well as its many essential physiological functions and the diverse pathologies that result from dysregulation. In response to ER Ca 2+ depletion, CRAC channels are formed through a diffusion trap mechanism at ER-plasma membrane (PM) junctions, where the ER Ca 2+ sensing stromal interaction molecule (STIM) proteins bind and activate hexamers of Orai pore-forming proteins to trigger Ca 2+ entry. Cell biological studies are clarifying the architecture of ER-PM junctions, their roles in Ca 2+ and lipid transport, and functional interactions with cytoskeletal proteins. Key structural studies of STIM and Orai have inspired mutagenesis and electrophysiological approaches that now suggest novel mechanisms that control toggling of STIM between inactive and active states, models for STIM-Orai binding and channel gating, and how STIM binding to all six Orai channel subunits triggers opening while establishing signature CRAC channel characteristics including extremely high Ca 2+ selectivity and low Ca 2+ conductance. OVERVIEW OF STORE-OPERATED CALCIUM ENTRY One of the major pathways for Ca 2+ influx across the plasma membrane (PM) of cells is store-operated Ca 2+ entry (SOCE), so called because it is triggered by stimuli that reduce the level of Ca 2+ in the endoplasmic reticulum (ER); aka the major cellular "Ca 2+ store") (Putney 1986). Initially described in electrically non-excitable cells, SOCE is now known to operate in practically all cells, including excitable cells such as neurons and muscle. At a cellular level, SOCE controls a wide variety of processes, including gene expression, secretion, motility, and maintaining a high Ca 2+ concentration in the ER. Its physiological importance is underscored by numerous pathologies caused by gain or loss of function. In humans, loss of function leads to severe combined immunodeficiency (SCID), autoimmunity, myopathy, and ectodermal dysplasia, while gain of function causes York and Stormorken syndromes (characterized by thrombocytopenia, bleeding diathesis, miosis, and tubular aggregate myopathy) (Lacruz and Feske 2015). The dire consequences of dysregulation demonstrate the importance of precisely controlling SOCE to drive a variety of essential physiological functions.